ACADIA Pharmaceuticals Inc. Watch

from 10-Q 11 pages ACADIA Pharmaceuticals Inc. Psu Award Grant Notice

from 8-K 9 pages Employment Agreement

from 8-K 9 pages ACADIA Pharmaceuticals Inc. Executive Transition Agreement

from 10-Q 5 pages February 22, 2024 Equity Award: A)

from 10-Q 18 pages Acadia Pharmaceuticals Inc. Performance Stock Unit Grant Notice

from 10-Q 11 pages Acadia Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice

from 10-Q 7 pages Acadia Pharmaceuticals Inc. Nonstatutory Stock Option Grant Notice

from 10-K 39 pages Commercial Supply Agreement

from 10-K 9 pages Product Agreement

from 10-K 32 pages Commercial Supply Agreement

from 10-K 37 pages Master Commercial Supply Agreement

from 10-K 7 pages Third Amendment to Product Agreement Between Patheon Pharmaceuticals Inc. and Acadia Pharmaceuticals Inc

from 10-K 6 pages Second Amendment to Product Agreement Between Patheon Pharmaceuticals Inc. and Acadia Pharmaceuticals Inc. 2

from 10-K 5 pages First Amendment to Product Agreement Between Patheon Pharmaceuticals Inc. and Acadia Pharmaceuticals Inc. 2

from 10-K 61 pages Master Manufacturing Services Agreement August 3, 2015

from 10-K 5 pages Material contract

from 10-K 13 pages Acadia Pharmaceuticals, Inc. Restricted Stock Unit Award Grant Notice 2010 Equity Incentive Plan

from 10-Q 80 pages Joint Venture and Licence Agreement

from 10-K 61 pages Lease and Lease Agreement Between Boston Properties Limited Partnership the Landlord and Acadia Pharmaceuticals Inc. the Tenant for Leased Premises in 502 Carnegie Center Princeton, New Jersey May 15, 2018

from 10-K 5 pages We Are Delighted to Offer You the Position of Executive Vice President, Research and Development With Acadia Pharmaceuticals Inc. as Discussed With You, This Offer Is Contingent Subject to Your Satisfactory Completion of a Background Investigation. the Start Date for Your Employment With Acadia Will Be Mutually Agreed to by You and Steve Davis. the Following Summarizes the Terms of Our Offer: Base Salary Your Semi-Monthly Salary Will Be $22,500.00 ($540,000.00 Annualized). Your Position Is Full Time and Is Exempt/Salaried. Performance Bonus You Will Be Eligible to Receive an Annual Performance Bonus Currently Targeted at 50% of Your Annual Base Salary and Will Be Granted in at the Discretion of the CEO and Board Based Upon Its Evaluation of the Company’s and Your Achievements Specific to Established Performance Goals. Equity Award A)